Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA
NCT04078191
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision.
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Tc 99m tilmanocept
Sponsor
Navidea Biopharmaceuticals